Search
Elevance Health Inc
ELVAdd to Watchlist
432.000USD
-2.180-0.50%
Close 11-05 16:00（ET）
93.34BMarket Cap
18.27P/E TTM
After-hours 19:00 (ET)432.000USD+0.150+0.04%
After-hours 19:00 (ET)Elevance Health Inc (ELV) Stock Price Target & Forecast
Analyst Rating
Based on 24 analysts giving stock ratings to Elevance Health Inc in the past month.
Buy
6 Strong Buy
10 Buy
8 Hold
0 Sell
0 Strong Sell
Target Price
479.134USD+14.06%
ELV Analyst Recommendation Trends
In the current month, ELV has received 10 Buy Ratings, 8 Hold Ratings, and 0 Sell Ratings. ELV average Analyst price target in the last month is 479.134.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
6
6
6
5
5
5
4
4
10
10
10
10
9
8
8
8
8
8
9
10
11
12
12
12
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
24
24
25
25
25
25
24
24
ELV Analyst Rating for Peer Comparison
Updated: Nov 5, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Humana Inc
HUM
7
6
14
1
0
28
Unitedhealth Group Inc
UNH
7
17
4
0
0
28
Cigna Group
CI
6
13
8
0
0
27
Centene Corp
CNC
4
5
13
1
0
23
Molina Healthcare Inc
MOH
2
2
16
1
0
21
Alignment Healthcare Inc
ALHC
6
6
2
0
0
14
Progyny Inc
PGNY
4
6
2
0
0
12
Clover Health Investments Corp
CLOV
0
2
2
0
0
4
Financial Forecasting
Based on analysts' estimates, ELV EPS is projected to reach 2.084 in FY2026Q4, following reported EPS of 6.302 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
FY2027Q1
Forecast
10.82
6.21
4.68
2.08
12.29
Actual
8.03
6.74
6.30
--
--
Surprise
-25.84%
+8.63%
+34.59%
--
--
FAQs
What is Elevance Health Inc's expected revenue for the next quarter?
Elevance Health Inc's expected revenue is 48.90B.
What is Elevance Health Inc's price target?
Analysts forecast that Elevance Health Inc's price target is USD 479.13, with the highest forecast at USD 523.00 and the lowest forecast at USD 406.00.
How have Elevance Health IncELV's recent earnings per share performed?
The market expectation was USD 6.30, while Elevance Health IncELV's earnings per share (EPS) for the previous quarter was USD 6.74. EPS for the next quarter is expected at USD 2.08.
What is the analyst rating for Elevance Health Inc?
Based on the ratings of Elevance Health Inc's stock from 24 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.